Contrast Medium Administration and Parameters Affecting Bolus Geometry in Multidetector Computed Tomography Angiography: An Overview

Biphasic split-bolus injection protocol for routine contrast-enhanced chest CT: comparison with conventional early-phase single bolus technique

OBJECTIVES

To present a routine contrast-enhanced chest CT protocol with a split-bolus injection technique achieving combined early- and delayed phase images with a single aquisition, and to compare this technique with a conventional early-phase single-bolus chest CT protocol we formerly used at our institution, in terms of attenuation of great thoracic vessels, pleura, included hepatic and portal venous enhancement, contrast-related artifacts, and image quality.

METHODS

A total of 202 patients, who underwent routine contrast-enhanced chest CT examination aquired with either conventional early-phase single-bolus technique (group A,n = 102) or biphasic split-bolus protocol (group B,n = 100), were retrospectively included. Attenuation measurements were made by two radiologists independently on mediastinal window settings using a circular ROI at the following sites: main pulmonary artery (PA) at its bifurcation level, thoracal aorta (TA) at the level of MPA bifurcation,portal vein (PV) at porta hepatis, left and right hepatic lobe, and if present, thickened pleura (>2 mm) at the level with the most intense enhancement. Respective normalized enhancement values were also calculated. Contrast-related artifacts were graded and qualitative evaluation of mediastinal lymph nodes was performed by both reviewers independently. Background noise was measured and contrast-to-noise ratios (CNRs) of the liver and TA were calculated.

RESULTS

While enhancement of thoracic vessels and normalised MPA enhancement did not differ significantly between both groups (p > 0.05), enhancement and normalised enhancement of pleura, liver parenchyma and PV was significantly greater in group B (p < 0.001). Perivenous artifacts limiting evaluation were less frequent in group B than in A and mediastinal lymph nodes were judged to be evaluated worse in group A than in group B with an excellent agreement between both observers. No significant difference was detected in CNRTA (p = 0.633), whereas CNR liver was higher in group B (p < 0.001).

CONCLUSION

Our split-bolus chest CT injection protocol enables simultaneous enhancement for both vascular structures and soft tissues, and thus, might raise diagnostic confidence without the need of multiple acquisitions.

ADVANCES IN KNOWLEDGE

We think that this CT protocol might also be a promising alternative in lung cancer staging, where combined contrast-enhanced CT of the chest and abdomen is indicated. We therefore suggest to further evaluate its diagnostic utility in this setting, in particular in comparison with a late delayed chest-upper abdominal CT imaging protocol.

Optimal delay for triple-phase hepatic computed tomography using a bolus-tracking technique in cats

The objective of this study was to provide the characteristics of hepatic computed tomography images and optimize their transition delay with a bolus-tracking technique for triple-phase hepatic computed tomography in cats. Dynamic triple-phase computed tomography was performed in nine healthy cats. The upper third of the liver was dynamically scanned every 0.5 s for 40 s. The time density curves of the aorta and hepatic parenchyma mean enhancement were analyzed. Triple-phase hepatic computed tomography was performed three times with a bolus trigger of 200 Hounsfield units of aortic enhancement. The transition delays of the arterial, portal, and hepatic parenchymal phases were respectively 0, 5 and 60 s in the first scan; 2, 7 and 62 s in the second scan; and 4, 9 and 64 s in the third scan. All computed tomography images were evaluated by a certificated radiologist. The arterial vessels and their main branches were well enhanced at a 2 s transition delay. The contrast of the portal vein to the liver parenchyma was most obvious at a 7 s transition delay. The mean enhancement of the hepatic parenchyma peaked at a 62 s transition delay, whereas the degree of enhancement of the hepatic vasculature decreased. In this study, the recommended transition delays for the arterial, portal, and hepatic parenchymal phases were 2 s, 7 s and 62 s, respectively, after triggering at 200 Hounsfield units of aortic enhancement. This information may be helpful in diagnosing feline liver diseases and provides a key reference for the clinical implementation of CT.

Stroke in Patients with Left Ventricular Assist Devices

BACKGROUND

Left ventricular assist devices (LVADs) are artificial pumps used in end-stage heart failure to support the circulatory system. These cardiac assist devices work in parallel to the heart, diverting blood from the left ventricle through an outflow graft and into the ascending aorta. LVADs have allowed patients with end-stage heart failure to live longer and with improved quality of life compared to best medical therapy alone. However, they are associated with significant risks related to both thrombosis and bleeding in this medically complex patient population. As LVADs continue to be used more widely, stroke neurologists need to become familiar with the unique physical exam and vascular imaging findings associated with this population.

SUMMARY

Reported rates of LVAD-associated stroke at 2 years post-implantation range from 10 to 30%, which is significantly higher than in age-matched controls. There are approximately equal rates of ischemic and hemorrhagic strokes, and rates are highest during the peri-implantation period and in the first year of therapy. Risk factors associated with ischemic and hemorrhagic stroke in this cohort can be grouped into treatment-related factors, including specific devices and antithrombotic/anticoagulation strategy, and patient-related factors. Evidence for reperfusion therapy for acute stroke in this population is limited. Intravenous tissue plasminogen activator (IV-tPA) is often contraindicated as events may occur in the perioperative setting, or in the context of therapeutic anticoagulation. Endovascular therapy with successful recanalization is reported, but there is little experience documented in the published literature. Key messages: LVAD use is increasingly common. Given the high associated risks of stroke, neurologists will need to become increasingly familiar with an approach to assessment and therapy for LVAD patients with cerebrovascular issues.

Impact of various iodine concentrations of iohexol and iodixanol contrast media on image reconstruction techniques in a vascular-specific contrast media phantom: quantitative and qualitative image quality assessment

PURPOSE

The aim of our study is to investigate the impact of iodine quantification on image reconstruction when employing a vascular-specific contrast media phantom with varying iodine concentrations.

MATERIALS AND METHODS

A 30-cm phantom simulating arterial and venous blood vessel diameters was manufactured. Small (9 mm) and medium (12 mm) cylinders contained iodine concentrations from 10 to 100% while large (21 mm) cylinders were in quartiles from 25 to 100% diluted in blood equivalent medium. Each phantom was filled with either iohexol 350 mgI/mL (Group A) or iodixanol 320 mgI/mL (Group B) and then scanned separately. For each group, tube potential (80-140 kVp) and current (50-400 mAs) were changed and all image series were reconstructed with filtered back projection (FBP), hybrid-based iterative reconstruction (HBIR) and model-based iterative reconstruction (MBIR). Mean opacification was measured in all groups. All data were compared employing an independent t test and Pearson's correlation. Visual grading characteristic (VGC) and Cohens' kappa analyses were performed.

RESULTS

At 80 kVp, mean opacification using HBIR was significantly higher in Group B (2165 ± 1108 HU) than in Group A (2040 ± 1036 HU) (p < 0.009). At 140 kVp, MBIR and HBIR were greater in Group A (1704 ± 1033 HU and 1685 ± 1023 HU) versus Group B (1567 ± 1036 HU and 1567 ± 1034 HU) (p < 0.022). CNR using FBP, HBIR and MBIR was higher in Group B (46 ± 42 HU, 70 ± 163 HU and 83 ± 74 HU, respectively) than in Group A (43 ± 39 HU, 174 ± 130 HU and 80 ± 65 HU, respectively) (p < 0.0001-0.035). Qualitative image analysis demonstrated no difference in Cohen's kappa analysis. VGC was higher in Group A at all image reconstruction groups.

CONCLUSION

Iohexol outperforms iodixanol in observer performance when assessing image reconstruction techniques and iodine concentrations in a vascular-specific contrast media phantom.

State of the art of coronary computed tomography angiography

OBJECTIVES

The aim of this paper is to evaluate contrast media (CM) bolus geometry and opacification patterns in the coronary arteries with particular focus on patient, scanner and safety considerations during coronary computed tomography angiography (CCTA).

KEY FINDINGS

The rapid evolution of computed tomography (CT) technology has seen this imaging modality challenge conventional coronary angiography in the evaluation of coronary artery disease. Increases in spatial and temporal resolutions have enabled CCTA to become the modality of choice when evaluating the coronary vascular tree as an alternative in the diagnostic algorithm for acute chest pain. However, these new technologic improvements in scanner technology have imposed new challenges for the optimisation of CM delivery and image acquisition strategies.

CONCLUSION

Understanding basic CM-imaging principles is essential for designing optimal injection protocols according to each specific clinical scenario, independently of scanner technology.

IMPLICATIONS FOR PRACTICE

With rapid advances in CT scanner technology including faster scan acquisitions, the risk of poor opacification of coronary vasculature increases significantly. Therefore, awareness of CM delivery protocols is paramount to consistently provide optimal image quality at a low radiation dose.

Effect of bolus administration of non-ionic radiopaque contrast media on blood pressure variation

INTRODUCTION

Haemodynamic changes may occur with the rapid intravenous injection of contrast media due to the osmolality of such pharmaceuticals. This study sought to evaluate the effect of bolus administration of intravenous contrast media on blood pressure variation during the Contrast-Enhanced Computed Tomography (CECT) of the abdomen.

METHODS

The study included 74 patients who underwent abdominal CECT and they were placed in the first group receiving a maximum of 80 ml of iodinated contrast via pressure injector (4 ml/s). A further 74 patients, who underwent non-contrast enhanced abdominal CT, were placed in the second group in which 80 ml of normal saline was administered via the same manner. Patients with hypertension and who were on anti-hypertensive drugs were excluded from the study. Non-invasive blood pressure was monitored before the injection of contrast media/saline and immediately after the portal venous phase for the CECT scan and after 45 s following the administration of normal saline in the non-contrast CT group. Mean systolic and diastolic blood pressures from both groups were compared to find out the effect of contrast bolus administration on blood pressure variation.

RESULTS

Both systolic and diastolic blood pressure increased with the injection of contrast media among CECT scan group. No significant changes in systolic and diastolic blood pressure were found before and after the scan in the non-contrast group.

CONCLUSION

Bolus administration of 80 ml saline has no effect on blood pressure. The increased blood pressure in contrast enhanced studies was induced by the iodinated contrast media and not by the bolus effect.

256 Slice Multi-detector Computed Tomography Thoracic Aorta Computed Tomography Angiography: Improved Luminal Opacification Using a Patient-Specific Contrast Protocol and Caudocranial Scan Acquisition

CLINICAL RELEVANCE STATEMENT

Caudocranial scan direction and contrast injection timing based on measured patient vessel dynamics can significantly improve arterial and aneurysmal opacification and reduce both contrast and radiation dose in the assessment of thoracic aortic aneurysms (TAA) using helical thoracic computed tomography angiography (CTA).

OBJECTIVES

To investigate opacification of the thoracic aorta and TAA using a caudocranial scan direction and a patient-specific contrast protocol.

MATERIALS AND METHODS

Thoracic aortic CTA was performed in 160 consecutive patients with suspected TAA using a 256-slice computed tomography scanner and a dual barrel contrast injector. Patients were subjected in equal numbers to one of two contrast protocols. Patient age and sex were equally distributed across both groups. Protocol A, the department's standard protocol, consisted of a craniocaudal scan direction with 100 mL of contrast, intravenously injected at a flow rate of 4.5 mL/s. Protocol B involved a caudocranial scan direction and a novel contrast formula based on patient cardiovascular dynamics, followed by 100 mL of saline at 4.5 mL/s. Each scan acquisition comprised of 120 kVp, 200 mA with modulation, temporal resolution 0.27 seconds, and pitch 0.889:1. The dose length product was measured between each protocol and data generated were compared using Mann-Whitney U nonparametric statistics. Receiver operating characteristic analysis, visual grading characteristic (VGC), and κ analyses were performed.

RESULTS

Mean opacification in the thoracic aorta and aneurysm measured was 24 % and 55%, respectively. The mean contrast volume was significantly lower in protocol B (73 ± 10 mL) compared with A (100 ± 1 mL) (P<0.001). The contrast-to-noise ratio demonstrated significant differences between the protocols (protocol A, 18.2 ± 12.9; protocol B, 29.7 ± 0.61; P < 0.003). Mean effective dose in protocol B (2.6 ± 0.4 mSv) was reduced by 19% compared with A (3.2 ± 0.8 mSv) (P < 0.004). Aneurysmal detectability demonstrated significant increases by receiver operating characteristic and visual grading characteristic analysis for protocol B compared with A (P < 0.02), and reader agreement increased from poor to excellent.

CONCLUSIONS

Significant increase in the visualization of TAAs following a caudocranial scan direction during helical thoracic CTA can be achieved using low-contrast volume based on patient-specific contrast formula.

Comparison of Standard and Quadruple-Phase Contrast Material Injection for Artifacts, Image Quality, and Radiation Dose in the Evaluation of Head and Neck Cancer Metastases

PURPOSE

To investigate opacification of head and neck vasculature during computed tomography (CT) of supraclavicular lymph nodes with a quadruple-phase contrast media and saline dual-injection protocol.

MATERIALS AND METHODS

This retrospective study was institutional review board approved. In 180 consecutive patients, routine head and neck CT was performed with one of two protocols: protocol A, craniocaudal scan direction with 100 mL of contrast material injected intravenously as a single bolus; or protocol B, 100 mL of contrast material injected in four phases (phases 1-2, 60 mL of contrast material and saline injected at 2.5 mL/sec; phases 3-4, 40 mL of contrast material and saline injected at 2.5 mL/sec); both protocols had a fixed scan delay of 70 seconds. Attenuation of supraclavicular arteries and veins was measured with arteriovenous contrast ratio (AVCR) and contrast-to-noise ratio (CNR). Effective dose was calculated. Data were compared with the two-sample t test. Receiver operating characteristic (ROC) and visual grading characteristic analyses were performed.

RESULTS

Arterial attenuation was up to 20% higher (P < .05) after protocol B (mean ± standard deviation, 234.5 HU ± 33.2) than protocol A (160.0 HU ± 29.5). Venous system attenuation was significantly lower in protocol B (164.0 HU ± 17.0) than in protocol A (664.0 HU ± 12.0), with up to a 75% reduction (P < .0001). Protocol B generated significant (P < .0001) improvements in AVCR at multiple anatomic sites. At all anatomic levels, mean CNR with protocol B (34.4 HU ± 9.0) was significantly higher than that with protocol A (14.5 HU ± 14.0) (P < .0313). Effective dose was significantly reduced with protocol B (2.6 mSv ± 0.4 vs 3.2 mSv ± 0.8 with protocol A; P < .0041). ROC analysis demonstrated significantly higher area under the ROC curve for protocol B (P < .0022), with interreader agreement increasing from poor to excellent in lymph node visualization.

CONCLUSION

Significant improvement in lymph node visualization at the cervicothoracic junction is achieved with a quadruple-phase contrast media injection protocol.

Multidetector computed tomography in the evaluation of cirsoid aneurysm of the scalp--a manifestation of trauma

Cirsoid aneurysms of the scalp are a rare abnormality with severe cosmetic deformity and possibly of severe hemorrhage. They present as a diagnostic and management challenge, but evaluation with multidetector computed tomography is useful in the diagnosis and treatment planning of these clinically complex disorders of the extracranial circulation. We present a case report of a 38-year-old New Caledonian male who had a large pulsatile mass in his scalp, which had progressively increased in size since the age of 17 years. The clinical and imaging features are outlined, in addition to treatment and prognosis.